NCT02810860 (EPICS) is a NA clinical trial of Laparoscopic cholecystectomy in Gallstone Disease, sponsored by Nottingham University Hospitals NHS Trust.

Who is sponsoring NCT02810860?

NCT02810860 is sponsored by Nottingham University Hospitals NHS Trust.

What drugs are being tested in NCT02810860?

Interventions in NCT02810860: Laparoscopic cholecystectomy.

What condition does NCT02810860 study?

NCT02810860 studies Gallstone Disease.

Is NCT02810860 still recruiting?

NCT02810860 is currently completed. Last updated 20 February 2020.

Last reviewed 2020-02-20 · How we verify

NCT02810860: EPICS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multimedia Informed Consent & PROMs in Laparoscopic Cholecystectomy

Completed NA Last updated 20 February 2020

What this trial tests

NA trial testing Laparoscopic cholecystectomy in Gallstone Disease in 349 participants. Completed in 1 January 2019.

Timeline

18 August 2016

Primary endpoint
13 April 2018

1 January 2019

Quick facts

Lead sponsor	Nottingham University Hospitals NHS Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	349
Start date	18 August 2016
Primary completion	13 April 2018
Estimated completion	1 January 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

Laparoscopic cholecystectomy

Conditions studied

Gallstone Disease — all drugs for Gallstone Disease →

Sponsor

Nottingham University Hospitals NHS Trust

Who can join

Adults 18 to 85, any sex, with Gallstone Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Collection of PROMs (Patient Reported Outcome Measures) data from patients before and after an operation to remove their gallbladder for the treatment of symptomatic gallstones. This PROMs data will provide information to clinicians and trusts about the health gain following this type of surgery and the impact on patient's quality of life. This information will be collected by the implementation of the patient Website aboutmyop.org. This will not only allow patients to complete quality of life (PROMs) questionnaires online, but will also allow them to access information on their condition and necessary surgery, in addition to post-operative follow-up.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Digital Informed Consent: Modernising Information Sharing in Surgery to Empower Patients.
Parsons SL, Daliya P, Evans P, Lobo DN. · · 2023 · cited 5× · PMID 36463388 · DOI 10.1007/s00268-022-06846-w
Digital Follow-Up After Elective Laparoscopic Cholecystectomy: A Feasibility Study.
Daliya P, Carvell J, Rozentals J, Lobo DN, et al · · 2022 · cited 3× · PMID 35953737 · DOI 10.1007/s00268-022-06684-w
Utilising Electronic PROMs to Measure a Change in Health Following Elective Laparoscopic Cholecystectomy: A Feasibility Study.
Daliya P, Lobo DN, Parsons SL. · · 2022 · cited 3× · PMID 35610385 · DOI 10.1007/s00268-022-06588-9

Verify or expand the search:

Other trials of Laparoscopic cholecystectomy

Trials testing the same drug.

NCT07001423 — ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly · NA · recruiting
NCT07119203 — Surgical Techniques: Robotic Versus Conventional Laparoscopic Cholecystectomy IN Benign Gallbladder Disease · NA · recruiting
NCT07161960 — Early Versus Delayed Cholecystectomy After Percutaneous Cholecystostomy in Moderate and Severe Cholecystitis (ESCAPE) · NA · recruiting
NCT06459323 — the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Diffe · NA · not yet recruiting
NCT06685250 — Postoperative Pain After a Laparoscopic Cholecystectomy · NA · not yet recruiting

Other recruiting trials for Gallstone Disease

Currently open trials in the same condition.

NCT07307703 — TENS for Anxiety, Pain, and Satisfaction After Laparoscopic Cholecystectomy · NA · recruiting
NCT07421011 — Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 · Phase 1 · recruiting
NCT06405906 — A Randomized Controlled Trial Comparing Fat-free Versus Balanced (WHO) Diet in Gallstone Disease · NA · recruiting
NCT05689255 — Gut Microbiome and Metabolome in Patients With Gallstone Disease After Surgical and Endoscopic Interventions · recruiting
NCT05618626 — Prevention of NAFLD and CVD Through Lifestyle Intervention · NA · recruiting

Other Nottingham University Hospitals NHS Trust trials

Trials by the same sponsor.

NCT07350408 — Mapping Post-falls Organisational Processes in Care Homes · recruiting
NCT07036081 — A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial En · NA · completed
NCT07303569 — Prevention of Pressure Injury (PI) in Hospitalised Infants, Children, and Young People (CYP) (Aged 0-19 Years) · recruiting
NCT06572345 — Low EnerGy DiEt iN Adolescents With Obesity and Type 2 Diabetes: The LEGEND Study · NA · recruiting
NCT07136298 — Seizure Identification on the Intensive Care Unit (ICU) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02810860 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nottingham University Hospitals NHS Trust
Last refreshed: 20 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02810860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing